Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Circulatory

  • 1
    News

    No reduction in PE risk with vena cava filters after severe injury

    July 9, 2019

    MELBOURNE – “Given the cost and risks associated with a vena cava filter, our data suggest that there is no urgency to insert the filter in patients who can be treated with prophylactic anticoagulation within 7 days after injury,” the investigators wrote.

  • 1
    News

    Rivaroxaban tied to higher GI bleeding than other NOACs

    June 17, 2019

    SAN DIEGO – Real-world studies comparing the GI bleeding rates among different non–vitamin K anticoagulants have been limited.

  • 1
    News

    Subsegmental PEs overtreated despite link with patient harm

    May 28, 2019

    How often are physicians treating isolated subsegmental pulmonary embolisms?

  • 1
    News

    Posthospitalization thromboprophylaxis with rivaroxaban is unnecessary

    May 21, 2019

    Do symptomatic venous thromboembolism (VTE) complications improve with posthospitalization thromboprophylaxis using rivaroxaban for an at-risk medical population?

  • 1
    News

    Rivaroxaban versus heparin at preventing recurrent, cancer-related VTE

    April 12, 2019

    Is an oral direct factor Xa inhibitor an effective alternative to low-molecular-weight heparin (LMWH) in treating cancer related venous thromboembolism (VTE)?

  • 1
    News

    IVC filter placement increases mortality in some VTE patients

    April 9, 2019

    How does inferior vena cava (IVC) filter placement affect 30-day mortality in patients with venous thromboembolism (VTE) with increased risk of bleeding when anticoagulation is not feasible?

  • 1
    News

    Ticagrelor reversal agent looks promising

    March 28, 2019

    NEW ORLEANS – Ticagrelor’s antiplatelet effect was squelched within 5 minutes.

  • 1
    News

    Occurrence of pulmonary embolisms in hospitalized patients nearly doubled during 2004-2015

    March 24, 2019

    NEW ORLEANS – National Inpatient Sample data showed that during 2004-2015 hospitalized U.S. patients with a PE diagnosis jumped by 80%.

  • 1
    News

    Andexanet alfa effectively reverses factor Xa inhibition

    March 18, 2019

    HONOLULU – The drug establishes good or excellent hemostasis in 82% of patients with acute major bleeding associated with factor Xa inhibition.

  • 1
    News

    Supplementary compression doesn’t improve DVT odds in critically ill

    February 20, 2019

    SAN DIEGO – The procedure carries few risks, aside from patient discomfort.

Previous1 … 10 11 12 13 14 … 25Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences